English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52844501    在线人数 :  685
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"yeh k h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 441-465 / 753 (共31页)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-11-02T02:04:36Z Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; MING-SHIANG WU; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L.
臺大學術典藏 2020-11-02T02:04:23Z The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21) Cheng A.-L.; Chen L.-T.; Hsu P.-N.; MING-SHIANG WU; Shun C.-T.; Wei M.-F.; Lee H.-W.; Yeh K.-H.; Lin C.-W.; Kuo S.-H.; Tsai H.-J.
臺大學術典藏 2020-11-02T02:04:23Z Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer MING-SHIANG WU; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.
臺大學術典藏 2020-11-02T02:04:20Z First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma Cheng A.-L.; Chen L.-T.; Wang H.-P.; Liou J.-M.; Wei M.-F.; Lin C.-W.; MING-SHIANG WU; Yeh K.-H.; Kuo S.-H.
臺大學術典藏 2020-09-29T06:53:04Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer Kuo S.-H.; Cheng A.-L.; Tien Y.-W.; Yeh K.-H.; Hsu C.-H.; Hsu C.; Wu H.; Guo J.-C.; TING-CHUN KUO; Yang S.-H.
臺大學術典藏 2020-09-29T06:53:03Z Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy Yeh K.-H.; Cheng A.-L.; TING-CHUN KUO; Tien Y.-W.; Kuo S.-H.; Guo J.-C.; Lee J.-C.; Yang S.-H.
臺大學術典藏 2020-09-29T01:47:44Z Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers Yeh K.-H.; Cheng A.-L.; Yang J.C.-H.; Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN; Hu F.-C.
臺大學術典藏 2020-08-13T06:33:59Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.; Chen K.-Y.; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.
臺大學術典藏 2020-06-16T07:53:31Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-06-16T07:53:29Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Liang-In Lin;Yeh K.-H.;Jeng Y.-M.; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; LIANG-IN LIN; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏 2020-06-16T07:53:23Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Chen K.-H.;Liang-In Lin;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; LIANG-IN LIN; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-06-03T08:10:43Z Panhypopituitarism caused by solitary parasellar metastasis from lung cancer Ko J.-C.; Yang P.-C.; TIEN-SHANG HUANG; Yeh K.-H.; Kuo S.-H.; Luh K.T.; Ko J.-C.;Yang P.-C.;Tien-Shang Huang;Yeh K.-H.;Kuo S.-H.;Luh K.T.
臺大學術典藏 2020-05-26T09:27:35Z Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome Yeh K.H;Hsieh H.C;Tang J.L;Lin M.T;Chih-Hsin Yang;Chen Y.C.; Yeh K.H; Hsieh H.C; Tang J.L; Lin M.T; CHIH-HSIN YANG; Chen Y.C.
臺大學術典藏 2020-05-26T09:27:35Z Long?�term disease?�free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third?�complementarity?�determining region?�specific probes Yeh K.??H;Lin M.??T;Tang J.??L;Chih-Hsin Yang;Tsay W;Chen Y.??C.; Yeh K.?�H; Lin M.?�T; Tang J.?�L; CHIH-HSIN YANG; Tsay W; Chen Y.?�C.
臺大學術典藏 2020-05-26T09:27:34Z MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer Hsu C;Yeh K.-H;Hong R.-L;Chih-Hsin Yang;Lin M.-T;Chen Y.-C;Cheng A.-L.; Hsu C; Yeh K.-H; Hong R.-L; CHIH-HSIN YANG; Lin M.-T; Chen Y.-C; Cheng A.-L.
臺大學術典藏 2020-05-26T09:27:33Z High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma Chih-Hsin Yang;Cheng A.-L;Yeh K.-H;Yu C.-J;Lin J.-F;Yang P.-C.; CHIH-HSIN YANG; Cheng A.-L; Yeh K.-H; Yu C.-J; Lin J.-F; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:31Z A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil Hsu C.-H;Cheng A.-L;Hsu C;Chih-Hsin Yang;Lu Y.-S;Lin C.-C;Bu C.-F;Yeh K.-H.; Hsu C.-H; Cheng A.-L; Hsu C; CHIH-HSIN YANG; Lu Y.-S; Lin C.-C; Bu C.-F; Yeh K.-H.
臺大學術典藏 2020-05-26T09:27:29Z Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract Hsu C;Shen Y.-C;Chih-Hsin Yang;Yeh K.-H;Lu Y.-S;Hsu C.-H;Liu H.-T;Li C.-C;Chen J.-S;Wu C.-Y;Cheng A.-L.; Hsu C; Shen Y.-C; CHIH-HSIN YANG; Yeh K.-H; Lu Y.-S; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L.
臺大學術典藏 2020-05-26T09:27:29Z Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma Lu Y.-S;Hsu C;Li C.-C;Kuo S.-H;Yeh K.-H;Chih-Hsin Yang;Hsu C.-H;Wu C.-Y;Cheng A.-L.; Lu Y.-S; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; CHIH-HSIN YANG; Hsu C.-H; Wu C.-Y; Cheng A.-L.
臺大學術典藏 2020-05-26T09:27:28Z Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer Yeh K.H;Lu Y.S;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Chih-Hsin Yang;Cheng A.L.; Yeh K.H; Lu Y.S; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; CHIH-HSIN YANG; Cheng A.L.
臺大學術典藏 2020-05-26T09:27:28Z Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment Chih-Hsin Yang;Chen M.-C;Cheng A.-L;Hsu C.-H;Yeh K.-H;Yu Y.-C;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Chen M.-C; Cheng A.-L; Hsu C.-H; Yeh K.-H; Yu Y.-C; Whang-Peng J; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:26Z Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer Hsu C.-H; Cheng J.C; Wang H.-P; Lee J.-M; Yeh K.-H; CHIH-HSIN YANG; Lin J.-T; Cheng A.-L; Lee Y.-C.; Lin C.-C;Hsu C.-H;Cheng J.C;Wang H.-P;Lee J.-M;Yeh K.-H;Chih-Hsin Yang;Lin J.-T;Cheng A.-L;Lee Y.-C.; Lin C.-C
臺大學術典藏 2020-05-26T09:27:25Z Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma Lin C.-C;Yeh K.-H;Chih-Hsin Yang;Hsu C;Tsai Y.-C;Hsu W.-L;Cheng A.-L;Hsu C.-H.; Lin C.-C; Yeh K.-H; CHIH-HSIN YANG; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H.
臺大學術典藏 2020-05-26T09:27:25Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C;Cheng A.-L;Hsu C.-H;Lu Y.-S;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Chih-Hsin Yang; Lin C.-C; Cheng A.-L; Hsu C.-H; Lu Y.-S; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:19Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C.

显示项目 441-465 / 753 (共31页)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
每页显示[10|25|50]项目